✉ Email this page to a colleague
« Back to Dashboard
Levo-t is a drug marketed by Cediprof Inc and is included in one NDA.
The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
A generic version of LEVO-T was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for LEVO-T
|Finished Product Suppliers / Packagers:||14|
|Raw Ingredient (Bulk) Api Vendors:||63|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for LEVO-T|
|What excipients (inactive ingredients) are in LEVO-T?||LEVO-T excipients list|
|DailyMed Link:||LEVO-T at DailyMed|
See the table below for patents covering LEVO-T around the world.
|Country||Patent Number||Title||Estimated Expiration|
|Japan||2003528931||See Plans and Pricing|
|Australia||5295301||See Plans and Pricing|
|World Intellectual Property Organization (WIPO)||0174448||See Plans and Pricing|
|Israel||152024||PHARMACEUTICAL COMPOSITIONS CONTAINING THYROID HORMONE AND PROCESSES FOR THE MANUFACTURE THEREOF||See Plans and Pricing|
|Canada||2404369||See Plans and Pricing|
|Brazil||0109736||See Plans and Pricing|
|Australia||2001252953||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|